The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 297-305

  Feske, Stefan ^a   Draeger, Ruth ^b   Peter, Hans Hartmut ^b   Eichmann, Klaus ^c   Rao, Anjana ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FAMILY; SCID MOUSE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034235929     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.297     Document Type: Article

References (64)

1. Lopez-Rodriguez, C., J. Aramburu, A. S. Rakeman, and A. Rao. 1999. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl. Acad. Sci. USA 96:7214.
2. Lopez-Rodriguez, C., J. Aramburu, A. S. Rakeman, and A. Rao. 2000. NFAT5: the NFAT family of transcription factors expands in a new direction. Cold Spring Harbor Symp. Quant. Biol. 64:517.
3. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707.
4. 2+, calcineurin, and NFAT. Cell 96:611.
5. Kiani, A., A. Rao, and J. Aramburu. 2000. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity, 12:359.
6. Serfling, E., A. Avots, and M. Neumann. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta 1263:181.
7. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333.
8. Duncliffe, K. N., A. G. Bert, M. A. Vadas, and P. N. Cockerill. 1997. A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site. Immunity 6:175.
9. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Serfling. 1993. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21:5694.
10. Rooney, J. W., M. R. Hodge, P. G. McCaffrey, A. Rao, and L. H. Glimcher. 1994. A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J. 13:625.
11. Szabo, S. J., J. S. Gold, T. L. Murphy, and K. M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NFATc. Mol. Cell. Biol. 13:4793.
12. Lee, H. J., E. S. Masuda, N. Arai, K. Arai, and T. Yokota. 1995. Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter: involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression. J. Biol. Chem. 270:17541.
13. Masuda, E. S., H. Tokumitsu, A. Tsuboi, J. Shlomai, P. Hung, K. Arai, and N. Arai. 1993. The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to API and NFAT. Mol. Cell. Biol. 13:7399.
14. Cockerill, P. N., M. F. Shannon, A. G. Bert, G. R. Ryan, and M. A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90:2466.
15. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-κB and NFAT with the interferon-γ promoter. J. Biol. Chem. 272:30412.
16. Campbell, P. M., J. Pimm, V. Ramassar, and P. F. Halloran. 1996. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-γ promoter that is a potential NFAT binding site. Transplantation 61:933.
17. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger, and A. Rao. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor a gene promoter. J. Exp. Med. 178:1365.
18. McCaffrey, P. G., A. E. Goldfeld, and A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J. Biol. Chem. 269:30445.
19. Dolganov, G., S. Bort, M. Lovett, J. Burr, L. Schubert, D. Short, M. McGurn, C. Gibson, and D. B. Lewis. 1996. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87:3316.
20. Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427.
21. Tsytsykova, A. V., E. N. Tsitsikov, and R. S. Geha. 1996. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 271:3763.
22. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
23. Liu, J. 1993. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today 14:290.
24. Shaw, K. T., A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P. G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 92:11205.
25. Loh, C., K. T. Shaw, J. Carew, J. P. Viola, C. Luo, B. A. Perrino, and A. Rao. 1996. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. Biol. Chem. 271:10884.
26. 2+ signals and immunosuppression. Nature 383:837.
27. Feske, S., J. M. Muller, D. Graf, R. A. Kroczek, R. Drager, C. Niemeyer, P. A. Baeuerle, H. H. Peter, and M. Schlesier. 1996. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur. J. Immunol. 26:2119.
28. Hoey, T., Y. L. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NFAT gene family and functional characterization of the NFAT proteins. Immunity 2:461.
29. Lyakh, L., P. Ghosh, and N. R. Rice. 1997. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17:2475.
30. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
31. Blumenthal, D. K., K. Takio, R. S. Hansen, and E. G. Krebs. 1986. Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase: determinants of substrate specificity. J. Biol. Chem. 261:8140.
32. Wolff, B., J. J. Sanglier, and Y. Wang. 1997. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4:139.
33. Fruman, D. A., C. B. Klee, B. E. Bierer, and S. J. Burakoff. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89:3686.
34. Rusnak, F., A. H. Beressi, A. Haddy, and A. Tefferi. 1996. Calcineurin protein phosphatase activity in peripheral blood lymphocytes. Bone Marrow Transplant. 17:309.
35. Agarwal, S., and A. Rao. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765.
36. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051.
37. Nigg, E. A. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386:779.
38. Nishi, K., M. Yoshida, D. Fujiwara, M. Nishikawa, S. Horinouchi, and T. Beppu. 1994. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269:6320.
39. Kehlenbach, R. H., A. Dickmanns, and L. Gerace. 1998. Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT In vitro. J. Cell Biol. 141:863.
40. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crabtree. 1997. Nuclear export of NFATc enhanced by glycogen synthase kinase-3. Science 275: 1930.
41. Zhu, J., F. Shibasaki, R. Price, J. C. Guillemot, T. Yano, V. Dotsch, G. Wagner, P. Ferrara, and F. McKeon. 1998. Intramolecular masking of nuclear import signal on NFAT4 by casein kinase 1 and MEKK1. Cell 93:851.
42. Rao, A. 1994. NFATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274.
43. Jain, J., V. E. Valge-Archer, A. J. Sinskey, and A. Rao. 1992. The AP-1 site at -150 bp, but not the NF-κB site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. J. Exp. Med. 175:853.
44. Tjian, R., and T. Maniatis. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5.
45. Chatila, T., E. Castigli, R. Pahwa, S. Pahwa, N. Chirmule, N. Oyaizu, R. A. Good, and R. S. Geha. 1990. Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes. Proc. Natl. Acad. Sci. USA 87:10033.
46. Castigli, E., R. Pahwa, R. A. Good, R. S. Geha, and T. A. Chatila. 1993. Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency. Proc. Natl. Acad. Sci. USA 90:4728.
47. Fischer, M. B., I. Hauber, H. Eggenbauer, V. Thon, E. Vogel, E. Schaffer, J. Lokaj, J. Litzman, H. M. Wolf, J. W. Mannhalter, et al. 1994. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeticiency. Blood 84:4234.
48. Hauber, I., M. B. Fischer, M. Maris, and M. M. Eibl. 1995. Reduced IL-2 expression upon antigen stimulation is accompanied by deficient IL-9 gene expression in T cells of patients with CVID. Scand. J. Immunol. 41:215.
49. + T cell differentiation. J. Clin. Immunol. 13:247.
50. Basu, D., C. B. Williams, and P. M. Allen. 1998. In vivo antagonism of a T cell response by an endogenously expressed ligand. Proc. Natl. Acad. Sci. USA 95: 14332.
51. Beverly, B., S. M. Kang, M. J. Lenardo, and R. H. Schwartz. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661.
52. Mueller, D. L., L. Chiodetti, P. A. Bacon, and R. H. Schwartz. 1991. Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones. J. Immunol. 147:4118.
53. + T cells. Science 271:1272.
54. Mondino, A., C. D. Whaley, D. R. DeSilva, W. Li, M. K. Jenkins, and D. L. Mueller. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157:2048.
55. Kang, S. M., B. Beverly, A. C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134.
56. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
57. Yoshida, H., H. Nishina, H. Takimoto, L. E. M. Marengere, A. C. Wakeham, D. Bouchard, Y. Y. Kong, T. Ohteki, A. Shahinian, M. Bachmann, et al. 1998. The transcription factor NFATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115.
58. Ranger, A. M., M. Oukka, J. Rengarajan, and L. H. Glimcher. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627.
59. Aramburu, J., M. B. Yaffe, C. Lopez-Rodriguez, L. C. Cantley, P. G. Hogan, and A. Rao. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129.
60. Xanthoudakis, S., J. P. Viola, K. T. Shaw, C. Luo, J. D. Wallace, P. T. Bozza, D. C. Luk, T. Curran, and A. Rao. 1996. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272:892.
61. Schuh, K., B. Kneitz, J. Heyer, U. Bommhardt, E. Jankevics, F. Berberich-Siebelt, K. Pfeffer, H. K. Muller-Hermelink, A. Schimpl, and E. Serfling. 1998. Retarded thymic involution and massive germinal center formation in NFATp-deficient mice. Eur. J. Immunol. 28:2456.
62. Hodge, M. R., A. M. Ranger, F. C. de la Brousse, T. Hoey, M. J. Grusby, and L. H. Glimcher. 1996. Hyperproliferation and dysregulation of IL-4 expression in NFATp-deficient mice. Immunity 4:397.
63. de la Pompa, J. L., L. A. Timmerman, H. Takimoto, H. Yoshida, A. J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B. L. Langille, et al. 1998. Role of the NFATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182.
64. Ranger, A. M., M. J. Grusby, M. R. Hodge, E. M. Gravallese, F. C. de la Brousse, T. Hoey, C. Mickanin, H. S. Baldwin, and L. H. Glimcher. 1998. The transcription factor NFATc is essential for cardiac valve formation. Nature 392:186.